Pharma-Bio Serv (PBSV) Free Cash Flow Growth (3y) (2013 - 2026)
Pharma-Bio Serv (PBSV) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn | 30.79% |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn | 47.95% |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn | 53.56% |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn | - |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn | 32.96% |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn | 40.06% |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | - |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn | -54.61% |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn | 54.31% |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | -34.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -34.85% |
| Oct 31, 2025 | 4.05% |
| Jul 31, 2025 | -40.33% |
| Apr 30, 2025 | 12.12% |
| Jan 31, 2025 | -9.41% |
| Oct 31, 2024 | -27.69% |
| Jul 31, 2024 | -52.14% |
| Apr 30, 2024 | 16.12% |
| Jan 31, 2024 | 7.38% |
| Oct 31, 2023 | -2.07% |
| Jul 31, 2023 | -7.51% |
| Apr 30, 2023 | 45.90% |
| Jan 31, 2023 | -16.74% |
| Oct 31, 2022 | 34.84% |
| Jul 31, 2022 | 55.13% |
| Apr 30, 2022 | 19.34% |
| Jan 31, 2022 | -14.09% |
| Oct 31, 2021 | 34.77% |
| Jul 31, 2021 | -36.00% |
| Apr 30, 2021 | -113.74% |